Brandes Axel, Smit Marcelle D, Nguyen Bao Oanh, Rienstra Michiel, Van Gelder Isabelle C
Department of Cardiology, Cardiology Research Unit, Odense University Hospital, University of Southern Denmark Odense, Denmark.
Thoraxcentre, University of Groningen, University Medical Centre Groningen, The Netherlands.
Arrhythm Electrophysiol Rev. 2018 Jun;7(2):118-127. doi: 10.15420/aer.2018.18.2.
Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with increased morbidity and mortality. There is growing evidence that numerous cardiovascular diseases and risk factors are associated with incident AF and that lone AF is rare. Beyond oral anticoagulant therapy, rate and rhythm control, therapy targeting risk factors and underlying conditions is an emerging AF management strategy that warrants better implementation in clinical practice. This review describes current evidence regarding the association between known modifiable risk factors and underlying conditions and the development and progression of AF. It discusses evidence for the early management of underlying conditions to improve AF outcomes. It also provides perspective on the implementation of tailored AF management in daily clinical practice.
心房颤动(AF)是最常见的临床心律失常,与发病率和死亡率增加相关。越来越多的证据表明,多种心血管疾病和危险因素与新发房颤相关,而孤立性房颤很少见。除口服抗凝治疗、心率和节律控制外,针对危险因素和基础疾病的治疗是一种新兴的房颤管理策略,值得在临床实践中更好地实施。本综述描述了关于已知可改变危险因素和基础疾病与房颤发生和进展之间关联的现有证据。它讨论了早期治疗基础疾病以改善房颤结局的证据。它还提供了在日常临床实践中实施个体化房颤管理的观点。